Charles A Sanders insider trades: Biocryst Pharmaceuticals (BCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
and 4 more companies
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2012 | BCRX | ↑ Buy | 2,000 | $5.21 | $10K | Direct | Mar 15, 2012 (2d) |
| Aug 10, 2011 | BIOD | ↑ Buy | 10,000 | $1.16 | $12K | Direct | Aug 11, 2011 (1d) |
| May 11, 2010 | BIOD | ↑ Buy | 5,000 | $5.59 | $28K | Direct | May 13, 2010 (2d) |
| Feb 8, 2010 | BCRX | ↑ Buy | 5,000 | $6.66 | $33K | Direct | Feb 9, 2010 (1d) |
| May 18, 2009 | VRTX | ↓ Sell | 3,333 | $28.44 | $95K | Direct | May 19, 2009 (1d) |
| May 11, 2009 | VRTX | ↓ Sell | 3,333 | $30.41 | $101K | Direct | May 12, 2009 (1d) |
| May 4, 2009 | VRTX | ↓ Sell | 3,334 | $30.08 | $100K | Direct | May 5, 2009 (1d) |
| May 27, 2008 | VRTX | ↓ Sell | 3,333 | $26.74 | $89K | Direct | May 28, 2008 (1d) |
| May 20, 2008 | VRTX | ↓ Sell | 3,333 | $27.60 | $92K | Direct | May 21, 2008 (1d) |
| May 13, 2008 | VRTX | ↓ Sell | 3,334 | $27.19 | $91K | Direct | May 15, 2008 (2d) |
| Feb 6, 2008 | DNA | ↓ Sell | 15,000 | $71.01 | $1.1M | Direct | Feb 8, 2008 (2d) |
| May 7, 2007 | VRTX | ↓ Sell | 10,000 | $30.53 | $305K | Direct | May 8, 2007 (1d) |
| Dec 8, 2006 | VRTX | ↓ Sell | 5,000 | $43.56 | $218K | Direct | Dec 11, 2006 (3d) |
| Dec 6, 2006 | VRTX | ↓ Sell | 3,000 | $44.71 | $134K | Direct | Dec 7, 2006 (1d) |
| Dec 5, 2006 | VRTX | ↓ Sell | 3,000 | $44.51 | $134K | Direct | Dec 6, 2006 (1d) |
| Dec 4, 2006 | VRTX | ↓ Sell | 3,000 | $44.28 | $133K | Direct | Dec 5, 2006 (1d) |
| Dec 1, 2006 | VRTX | ↓ Sell | 3,000 | $43.86 | $132K | Direct | Dec 4, 2006 (3d) |
| Nov 30, 2006 | VRTX | ↓ Sell | 3,000 | $44.54 | $134K | Direct | Dec 1, 2006 (1d) |
| Nov 23, 2005 | ICGN | ↑ Buy | 5,000 | $6.03 | $30K | Direct | Nov 28, 2005 (5d) |
| Aug 30, 2005 | BPUR | ↑ Buy | 10,000 | $1.42 | $14K | Direct | Aug 31, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BCRX insiders
Open-market trades in the last 12 months
About Charles A Sanders's insider trades
Charles A Sanders is a director at Biocryst Pharmaceuticals (BCRX). Since Aug 30, 2005, Charles has reported 6 open-market purchases worth $128K and 14 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (50 filings), option exercises (17 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.